Truist Financial
NVAX icon

Truist Financial’s Novavax NVAX Stock Holding History

Truist Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,657
Closed -$237K – 2791
2021
Q4 		$237K Sell
1,657
-3,048
-65% -$524K ﹤0.01% 2502
2021
Q3 		$975K Buy
4,705
+2,599
+123% +$573K ﹤0.01% 1620
2021
Q2 		$447K Buy
2,106
+409
+24% +$74.9K ﹤0.01% 2130
2021
Q1 		$308K Buy
+1,697
New +$338K ﹤0.01% 2269

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Truist Financial's NVAX Position: Q1 2022 in Review

Truist Financial sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,657 shares — an estimated $237K sold.

Truist Financial first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $975K in Q3 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Truist Financial reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 1,657 Novavax shares in Q1 2022, an estimated $237K.
  • Truist Financial first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
  • Truist Financial's Novavax position peaked at $975K in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.